Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02107235
Title Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Onconova Therapeutics, Inc.
Indications

oropharynx cancer

laryngeal squamous cell carcinoma

hypopharynx cancer

head and neck cancer

Therapies

Cisplatin

Rigosertib Sodium

Age Groups: adult
Covered Countries USA


No variant requirements are available.